XML 25 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Net Income per Common Share
9 Months Ended
Sep. 30, 2018
Earnings Per Share [Abstract]  
Net Income Per Common Share

Note 2 — Net Income per Common Share

 

 

 

Quarter Ended September 30,

 

 

Nine Months Ended September 30,

 

(In millions, except per share data)

 

2018

 

 

2017

 

 

2018

 

 

2017

 

Basic net income per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

80.1

 

 

$

69.7

 

 

$

210.5

 

 

$

195.9

 

Weighted average common shares outstanding

 

 

87.0

 

 

 

90.1

 

 

 

88.6

 

 

 

90.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic net income per common share

 

$

0.92

 

 

$

0.77

 

 

$

2.37

 

 

$

2.16

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted net income per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

80.1

 

 

 

69.7

 

 

 

210.5

 

 

 

195.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding — Basic

 

 

87.0

 

 

 

90.1

 

 

 

88.6

 

 

 

90.7

 

Plus incremental shares from assumed conversions:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restricted stock units

 

 

0.5

 

 

 

0.4

 

 

 

0.4

 

 

 

0.4

 

Stock options

 

 

0.6

 

 

 

0.9

 

 

 

0.7

 

 

 

1.0

 

Weighted average common shares outstanding — Dilutive

 

 

88.1

 

 

 

91.4

 

 

 

89.7

 

 

 

92.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted net income per common share

 

$

0.91

 

 

$

0.76

 

 

$

2.35

 

 

$

2.13

 

 

Total shares underlying stock options of 0.2 million were excluded from the computation of diluted net income per share for the three and nine months ended September 30, 2018, as they were anti-dilutive. Total shares underlying stock options of 0.1 million and 0.2 million, respectively, were excluded from the computation of diluted net income per share for the three and nine months ended September 30, 2017, as they were anti-dilutive.